| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/31/1994 | US5316754 In vitro assay of mesangial cell-derived receptors for advanced glycosylation endproducts |
| 05/31/1994 | CA2084120A1 Method of treating autoimmune diseases |
| 05/27/1994 | CA2102034A1 Antibody and method for its production |
| 05/26/1994 | WO1994011737A1 Method for detection of a new marker associated with hepatitis delta virus infection |
| 05/26/1994 | WO1994011522A2 Vector for the expression of therapy-relevant genes |
| 05/26/1994 | WO1994011521A1 Bovine heat shock promoter and uses thereof |
| 05/26/1994 | WO1994011513A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | WO1994011512A2 Allergenic proteins and peptides from japanese cedar pollen |
| 05/26/1994 | WO1994011509A2 Peptides and anti-sense peptides with broad neoplastic specificity |
| 05/26/1994 | WO1994011504A1 C-c ckr-1, c-c chemokine receptor |
| 05/26/1994 | WO1994011499A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 05/26/1994 | WO1994011497A1 Method of causing selective immunosuppression using hl-60-related lectins |
| 05/26/1994 | WO1994011490A2 Products of the inhibition of advanced glycosylation |
| 05/26/1994 | WO1994011405A1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 05/26/1994 | WO1994011403A1 Artificial antibodies, method of producing the same and use thereof |
| 05/26/1994 | WO1994011401A1 Human homolog of the e-cadherin gene and methods based thereon |
| 05/26/1994 | WO1994011029A1 Human tissue factor related dna segments, polypeptides and antibodies |
| 05/26/1994 | WO1994011027A1 Peripheralization of hematopoietic stem cells |
| 05/26/1994 | WO1994011026A2 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | WO1994011025A1 Pathogenic porcine respiratory coronavirus |
| 05/26/1994 | WO1994011024A1 Composition protective against p. multocida pasteurellosis infection |
| 05/26/1994 | WO1994011023A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 05/26/1994 | WO1994011020A1 Eck receptor ligands |
| 05/26/1994 | WO1994011019A1 Materials and methods for immunocontraception |
| 05/26/1994 | WO1994011016A1 Specific immune system modulation |
| 05/26/1994 | WO1994011011A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
| 05/26/1994 | WO1994006909A3 A method of preventing tumor metastasis |
| 05/26/1994 | CA2626445A1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | CA2149309A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | CA2149043A1 Artificial antibodies, method of producing the same and use thereof |
| 05/26/1994 | CA2148835A1 Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs |
| 05/26/1994 | CA2148829A1 Avirulent live vaccine and method for immunizing animals against p. multocida pasteurellosis |
| 05/26/1994 | CA2148713A1 Allergenic proteins and peptides from japanese cedar pollen |
| 05/26/1994 | CA2127531A1 Materials and methods for immunocontraception |
| 05/26/1994 | CA2126690A1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 05/26/1994 | CA2083812A1 Expression vectors and their use in the preparation of hiv-resistant human cells for therapeutic applications |
| 05/25/1994 | EP0598329A2 Simultaneous determination of HbA1c and haemoglobin variants with a HbA1c analog glycation |
| 05/25/1994 | EP0597852A1 Swine pneumonia vaccine and method for the preparation thereof |
| 05/25/1994 | EP0597847A1 Synthetic senescent cell antigen |
| 05/25/1994 | EP0597843A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) |
| 05/25/1994 | EP0597842A1 Metal binding proteins |
| 05/25/1994 | EP0597838A1 Vaccine compositions |
| 05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
| 05/25/1994 | EP0476063B1 Glucan drug delivery system and adjuvant |
| 05/25/1994 | EP0249629B1 Methods and materials for alleviation of pain symptoms of malignant neoplasia |
| 05/25/1994 | CN1087122A Method for production and purification of hepatitis Bvaccine |
| 05/24/1994 | US5314995 Antitumor |
| 05/24/1994 | US5314991 Recombinant 40 KDa Dermatophagoides farinae allergen |
| 05/24/1994 | US5314808 Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of a B viral hepatitis, and preparations containing the expression products of said DNAs |
| 05/24/1994 | US5314800 Purified human cytomegalovirus protein |
| 05/24/1994 | US5314690 Method and composition for treating IgE-mediated allergies |
| 05/24/1994 | US5314642 Hydrolysis |
| 05/24/1994 | CA1329766C T cell epitopes of the hepatitis b virus nucleocapsid protein |
| 05/19/1994 | DE4238778A1 Vektor zur Expression von therapeutisch relevanten Genen Vector for Expression of therapeutically relevant genes |
| 05/18/1994 | EP0597577A1 Separation of plasma or serum from whole blood using a red blood cell binding component and a polymer containing multiple cationic sites |
| 05/18/1994 | EP0597503A2 ECK receptor ligands |
| 05/18/1994 | EP0597101A1 Stabilized human monoclonal antibody preparation |
| 05/18/1994 | EP0597068A1 Process for the prenatal diagnosis of genetic abnormalities |
| 05/18/1994 | EP0597043A1 Porcine adipocyte antigens and their use in the immunological control of fat |
| 05/18/1994 | EP0597016A1 Infectious bursal disease virus recombinant poxvirus vaccine |
| 05/18/1994 | EP0596959A1 Self-adjuvanting peptide vaccine delivery system and production thereof |
| 05/18/1994 | EP0516749B1 Immobilized polyethylene oxide star molecules for bioapplications |
| 05/18/1994 | CA2103318A1 Simultaneous determination of hba1 and haemoglobin variants with a glycation analogous to hba1 |
| 05/17/1994 | US5312902 Dimer of the precursor of HIV-2 envelope glycoprotein |
| 05/17/1994 | US5312751 Hybridoma producing a monoclonal antibody specific for an antigen of the stratum corneum of human epidermis |
| 05/17/1994 | US5312737 CKS method of HCV protein synthesis |
| 05/17/1994 | US5312733 Developmental marker gene of CD4-CD8 thymocytes |
| 05/17/1994 | US5312620 Polymeric immunological adjuvants |
| 05/17/1994 | CA1329604C Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein, and processes for the preparation of these heterocyclic compounds |
| 05/17/1994 | CA1329544C Galenic forms of allergens for sublingual administration |
| 05/13/1994 | CA2102848A1 Altered affinity polypeptides of metal chelate binding antibodies |
| 05/11/1994 | WO1994010344A1 Diagnostic reagents and their use in the detection of human herpesvirus 7 |
| 05/11/1994 | WO1994010339A1 Evolutive vaccination |
| 05/11/1994 | WO1994010331A1 Angiogenesis inhibitory antibodies |
| 05/11/1994 | WO1994010321A1 Turkey herpesvirus vector as a recombinant infectious bursal disease vaccine |
| 05/11/1994 | WO1994010317A2 Conjugate vaccine against group b streptococcus |
| 05/11/1994 | WO1994010316A1 Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof |
| 05/11/1994 | WO1994010314A1 Allergenic proteins and peptides from johnson grass pollen |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
| 05/11/1994 | WO1994010307A1 Transcription factor dp-1 |
| 05/11/1994 | WO1994010304A1 Marmoset zona pellucida protein zp3 |
| 05/11/1994 | WO1994010303A1 Multidrug resistance gene |
| 05/11/1994 | WO1994010291A1 CULTURE CELLS OF $i(QUILLAJA SP.) |
| 05/11/1994 | WO1994010204A1 Protein fragments of the pectinatus bacterium |
| 05/11/1994 | WO1994010203A2 Op-3-induced morphogenesis |
| 05/11/1994 | WO1994010202A1 Vascular endothelial cell growth factor antagonists |
| 05/11/1994 | WO1994010201A1 Peptides and vaccines derived from nematode tubulin |
| 05/11/1994 | WO1994010198A1 Method of reducing multidrug resistance in cells and tissues |
| 05/11/1994 | WO1994010197A1 A novel protein tyrosine kinase |
| 05/11/1994 | WO1994010194A2 Molecule fragments (peptides) of the main allergens contained in the pollen of trees of the fagales order |
| 05/11/1994 | WO1994010172A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 05/11/1994 | WO1994010149A1 Molecule labelling using 2-hydraninopyridine derivatives |
| 05/11/1994 | WO1994009828A1 Dna encoding a human serotonin receptor (5-ht4b) and uses thereof |
| 05/11/1994 | WO1994009824A1 Allergenic extracts |
| 05/11/1994 | WO1994009823A1 Urease-based vaccine against helicobacter infection |
| 05/11/1994 | WO1994009822A1 IMMUNIZATION AGAINST NEISSERIA GONORRHOEAE AND $i(NEISSERIA MENINGITIDIS) |
| 05/11/1994 | WO1994009821A1 Recombinant vaccine for porcine pleuropneumoniae |
| 05/11/1994 | WO1994009820A1 Prostate-specific membrane antigen |
| 05/11/1994 | WO1994009819A1 Microcrystalline cellulose as an immune adjuvant |
| 05/11/1994 | WO1994009818A1 Method for stimulating production of variable region gene family restricted antibodies through b-cell superantigen vaccination |